Clinical trial
A Phase II Study on Trabectedin in Advanced Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
NCT02247544 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study on Trabectedin in Advanced Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
- Lead sponsor
- Italian Sarcoma Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- March 12, 2019
- Enrollment
- 105 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.